Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values.
Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.
SaaS, Healthcare, E-commerce
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Brightside Health is a telemedicine platform integrating precision psychiatry with advanced therapeutic techniques.
Revolutionizing Arrhythmia Care
Health Outlook use modern proteomics to better predict health events and improve health outcomes.
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Imagine Pharma is a drug discovery and development company that offers a platform to provide therapeutic and regenerative medicine.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
BBy is a medical device company that condenses breast milk and turns it into powder.
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Biopharma. The firm invests across 23 different industry categories.
Among tracked funding rounds, Mediar Therapeutics received $85.0M in a Series A round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include DiaMonTech AG, Simergent, Bask Health, Rallybio, Arnatar Therapeutics. These companies were founded in 2020 or later.